Name | Number of supported studies | Average coverage | |
---|---|---|---|
dendritic cell | 3 studies | 27% ± 13% | |
conventional dendritic cell | 3 studies | 24% ± 5% |
Insufficient scRNA-seq data for expression of RAB7B at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 98% | 1149.68 | 643 / 653 | 92% | 15.38 | 555 / 605 |
skin | 100% | 2503.79 | 1802 / 1809 | 90% | 19.19 | 423 / 472 |
lung | 98% | 852.20 | 565 / 578 | 88% | 22.84 | 1022 / 1155 |
uterus | 95% | 917.29 | 162 / 170 | 86% | 25.80 | 394 / 459 |
breast | 83% | 649.54 | 382 / 459 | 82% | 9.44 | 918 / 1118 |
prostate | 93% | 824.67 | 227 / 245 | 66% | 4.47 | 333 / 502 |
esophagus | 66% | 1008.33 | 958 / 1445 | 75% | 13.66 | 138 / 183 |
bladder | 81% | 734.33 | 17 / 21 | 57% | 8.58 | 289 / 504 |
ovary | 72% | 300.79 | 129 / 180 | 62% | 4.54 | 266 / 430 |
stomach | 83% | 450.57 | 298 / 359 | 50% | 2.80 | 143 / 286 |
pancreas | 9% | 30.09 | 29 / 328 | 89% | 12.63 | 159 / 178 |
tonsil | 0% | 0 | 0 / 0 | 93% | 33.06 | 42 / 45 |
brain | 27% | 138.79 | 712 / 2642 | 66% | 6.64 | 468 / 705 |
adipose | 91% | 983.35 | 1091 / 1204 | 0% | 0 | 0 / 0 |
intestine | 46% | 200.69 | 440 / 966 | 36% | 2.66 | 189 / 527 |
blood vessel | 78% | 499.72 | 1046 / 1335 | 0% | 0 | 0 / 0 |
kidney | 9% | 20.74 | 8 / 89 | 69% | 5.00 | 620 / 901 |
lymph node | 0% | 0 | 0 / 0 | 59% | 4.67 | 17 / 29 |
heart | 55% | 277.59 | 471 / 861 | 0% | 0 | 0 / 0 |
spleen | 47% | 172.88 | 114 / 241 | 0% | 0 | 0 / 0 |
liver | 3% | 10.93 | 6 / 226 | 33% | 2.74 | 134 / 406 |
adrenal gland | 10% | 27.52 | 25 / 258 | 15% | 1.03 | 35 / 230 |
muscle | 14% | 49.18 | 116 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 6% | 0.41 | 5 / 80 |
peripheral blood | 2% | 7.17 | 14 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0045654 | Biological process | positive regulation of megakaryocyte differentiation |
GO_0034144 | Biological process | negative regulation of toll-like receptor 4 signaling pathway |
GO_0034499 | Biological process | late endosome to Golgi transport |
GO_0051092 | Biological process | positive regulation of NF-kappaB transcription factor activity |
GO_0090385 | Biological process | phagosome-lysosome fusion |
GO_0008333 | Biological process | endosome to lysosome transport |
GO_0034164 | Biological process | negative regulation of toll-like receptor 9 signaling pathway |
GO_0015031 | Biological process | protein transport |
GO_0032755 | Biological process | positive regulation of interleukin-6 production |
GO_0071346 | Biological process | cellular response to type II interferon |
GO_0031902 | Cellular component | late endosome membrane |
GO_0005764 | Cellular component | lysosome |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0005802 | Cellular component | trans-Golgi network |
GO_0045335 | Cellular component | phagocytic vesicle |
GO_0005770 | Cellular component | late endosome |
GO_0030670 | Cellular component | phagocytic vesicle membrane |
GO_0005525 | Molecular function | GTP binding |
GO_0005515 | Molecular function | protein binding |
GO_0003924 | Molecular function | GTPase activity |
Gene name | RAB7B |
Protein name | RAB7B, member RAS oncogene family Ras-related protein Rab-7b |
Synonyms | |
Description | FUNCTION: Controls vesicular trafficking from endosomes to the trans-Golgi network (TGN). Acts as a negative regulator of TLR9 signaling and can suppress TLR9-triggered TNFA, IL6, and IFNB production in macrophages by promoting TLR9 lysosomal degradation. Also negatively regulates TLR4 signaling in macrophages by promoting lysosomal degradation of TLR4. Promotes megakaryocytic differentiation by increasing NF-kappa-B-dependent IL6 production and subsequently enhancing the association of STAT3 with GATA1. Not involved in the regulation of the EGF- and EGFR degradation pathway. . |
Accessions | ENST00000623893.1 A0A096LPF0 ENST00000617991.4 ENST00000623597.3 ENST00000622969.1 Q96AH8 ENST00000617070.5 A0A096LP44 |